Armetheon Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Armetheon Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8010866
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月20日
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Armetheon Inc (Armetheon) is a drug development company that develops novel small molecule drugs for treatment of cardiovascular diseases with high unmet medical need. The company develops anticoagulants and antibiotics that make use of the antibiotic resistance mechanisms to provide bactericidal activities. Armetheon’s pipeline products consists of indications for thrombosis and atrial fibrillations. The company’s products offer potential for treatment in patients with atrial fibrillation who are eligible for ablation or re-ablation. It caters to pharmaceutical and biotechnology sectors. Armetheon is headquartered in Milpitas, California, the US.

Armetheon Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Armetheon Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Armetheon Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Armetheon Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Armetheon Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Armetheon Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Armetheon Inc, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Armetheon Acquires Rights To Three Drugs From ARYx Therapeutics 10
Venture Financing 11
Armetheon Raises USD24 Million in Series B Financing 11
Armetheon Raises USD7 Million in Series A Venture Financing 12
Armetheon Raises Funds Through Seed Financing 13
Merger 14
Espero Pharma and Armetheon to Merge 14
Licensing Agreements 15
China Cardiovascular Focus Enters into Licensing Agreement with Armetheon 15
Armetheon Inc – Key Competitors 16
Armetheon Inc – Key Employees 17
Armetheon Inc – Locations And Subsidiaries 18
Head Office 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Armetheon Inc, Pharmaceuticals & Healthcare, Key Facts 2
Armetheon Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Armetheon Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Armetheon Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Armetheon Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Armetheon Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Armetheon Acquires Rights To Three Drugs From ARYx Therapeutics 10
Armetheon Raises USD24 Million in Series B Financing 11
Armetheon Raises USD7 Million in Series A Venture Financing 12
Armetheon Raises Funds Through Seed Financing 13
Espero Pharma and Armetheon to Merge 14
China Cardiovascular Focus Enters into Licensing Agreement with Armetheon 15
Armetheon Inc, Key Competitors 16
Armetheon Inc, Key Employees 17

★海外企業調査レポート[Armetheon Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Orbis Biosciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Orbis Biosciences Inc (Orbis) is a developer of pharmaceutical products that offers optimizes oral and injectable products. The company provides preclnical pipeline indications for pathologies including cancer, bronchiolitis, Eczema, atopic dermatitis, nephrotic syndrome, HIV, asthma, bunine …
  • Instituto Costarricense de Electricidad:企業の戦略的SWOT分析
    Instituto Costarricense de Electricidad - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and m …
  • BioMedomics Inc-医療機器分野:企業M&A・提携分析
    Summary BioMedomics Inc (BioMedomics) is a point-of-care diagnostics company that develops immunologically-based disease-specific tests and advanced highly sensitive quantitative platforms. The company provides technologies such as time-resolved lateral flow immunoassay and nanotube based POC platfo …
  • OcuNexus Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary OcuNexus Therapeutics Inc (OcuNexus Therapeutics) is a development stage biopharmaceutical company engaged in novel therapeutics for unmet clinical needs in ophthalmology. It has highly differentiated, lead drug candidates based upon a novel mechanism of action such as Gap Junction Channel M …
  • Oncolix Inc (ONCX):製薬・医療:M&Aディール及び事業提携情報
    Summary Oncolix Inc (Oncolix) is a clinical stage biotechnology company. It is developing a targeted therapeutic protein, Prolanta for the treatment of ovarian, breast and other cancers. Prolanta is a recombinant analogue to the human prolactin and acts as an antagonist to the prolactin receptor. On …
  • Gland Pharma Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Gland Pharma Ltd (Gland Pharma) is a healthcare products provider that develops and manufactures active pharmaceutical ingredients. The company’s products include injectables, pre filled syringes, vials, ampoules, infusions, ophthalmic solutions, lyophilized vials, dry powders, lyophilized p …
  • CJ ENM Co., Ltd. (035760):企業の財務・戦略的SWOT分析
    CJ ENM Co., Ltd. (035760) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Dong-A Socio Holdings Co Ltd (000640):企業の財務・戦略的SWOT分析
    Dong-A Socio Holdings Co Ltd (000640) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Tesla, Inc.:企業の戦略・SWOT・財務分析
    Tesla, Inc. - Strategy, SWOT and Corporate Finance Report Summary Tesla, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • CRH Medical Corp (CRH)-医療機器分野:企業M&A・提携分析
    Summary CRH Medical Corp (CRH Medical), formerly Medsurge Medical Products Corp is a medical device company that provides treatment of hemorrhoids. The company provides CRH O’Regan System, a hemorrhoid technology for treating hemorrhoid. It provides topical ointments and creams including preparation …
  • AIA Insurance Lanka Plc (CTCE.N0000):企業の財務・戦略的SWOT分析
    AIA Insurance Lanka Plc (CTCE.N0000) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Pt Pioneerindo Gourmet International Tbk:企業の戦略・SWOT・財務分析
    Pt Pioneerindo Gourmet International Tbk - Strategy, SWOT and Corporate Finance Report Summary Pt Pioneerindo Gourmet International Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Sirius International Insurance Corp:企業の戦略・SWOT・財務分析
    Sirius International Insurance Corp - Strategy, SWOT and Corporate Finance Report Summary Sirius International Insurance Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • The Tata Power Co Ltd (TATAPOWER):企業の財務・戦略的SWOT分析
    The Tata Power Co Ltd (TATAPOWER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Community Trust Bancorp Inc:企業の戦略・SWOT・財務情報
    Community Trust Bancorp Inc - Strategy, SWOT and Corporate Finance Report Summary Community Trust Bancorp Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Avenue Supermarts Limited (DMART):企業の財務・戦略的SWOT分析
    Avenue Supermarts Limited (DMART) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Xcel Energy Inc (XEL)-エネルギー分野:企業M&A・提携分析
    Summary Xcel Energy Inc. (Xcel Energy) is a vertically-integrated energy utility that generates, procures, transmits, distributes and sells electricity; and transports, stores and distributes natural gas through its subsidiaries. The company owns and operates generation assets utilizing diverse fuel …
  • Yoho Resources Inc. (YO)-石油・ガス分野:企業M&A・提携分析
    Summary Yoho Resources Inc. (Yoho) is an upstream oil and gas exploration company. The company carries out exploration, development and production of crude oil and natural gas liquid, and natural gas. The company has operations within the Western Canadian Sedimentary Basin focusing exploration activ …
  • ePlus Inc (PLUS):企業の財務・戦略的SWOT分析
    ePlus Inc (PLUS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Tokyo Electron Limited:企業の戦略・SWOT・財務分析
    Tokyo Electron Limited - Strategy, SWOT and Corporate Finance Report Summary Tokyo Electron Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆